These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26486998)

  • 21. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
    Wang X; Zhang L; Zhang X; Luo J; Wang X; Chen X; Yang Z; Mei X; Yu X; Zhang Z; Guo X; Shao Z; Ma J
    Breast Cancer Res Treat; 2021 Nov; 190(2):277-286. PubMed ID: 34490502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
    Wright JL; Takita C; Reis IM; Zhao W; Saigal K; Wolfson A; Markoe A; Moller M; Hurley J
    Cancer; 2013 Jan; 119(1):16-25. PubMed ID: 22736498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates.
    Bazan JG; Majithia L; Quick AM; Wobb JL; Terando AM; Agnese DM; Farrar W; White JR
    Ann Surg Oncol; 2018 Aug; 25(8):2288-2295. PubMed ID: 29916008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.
    Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM
    Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmastectomy radiation therapy in T3 node-negative breast cancer.
    Elmore L; Deshpande A; Daly M; Margenthaler JA
    J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy.
    Sayan M; Vergalasova I; George M; Kowzun M; Potdevin L; Kumar S; Haffty B; Ohri N
    Turk J Med Sci; 2022 Apr; 52(2):279-285. PubMed ID: 36161617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmastectomy radiation therapy for triple negative, node-negative breast cancer.
    Haque W; Verma V; Farach A; Brian Butler E; Teh BS
    Radiother Oncol; 2019 Mar; 132():48-54. PubMed ID: 30825969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying factors impacting the efficacy of postmastectomy radiotherapy in patients with early-stage breast cancer and one to two positive lymph nodes.
    Bhutiani N; Egger ME; Stromberg AJ; Bhutiani IK; Ajkay N; McMasters KM
    J Surg Oncol; 2020 Aug; 122(2):128-133. PubMed ID: 32334441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysis.
    Lin J; Li C; Zhang C; Shi F; Wang H
    Future Oncol; 2017 Jul; 13(16):1395-1404. PubMed ID: 28381104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
    Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
    Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.
    Shi Z; Peddi P; Burton G; Mills G; Shi R
    Anticancer Res; 2016 Jan; 36(1):261-9. PubMed ID: 26722052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database.
    Yu JB; Wilson LD; Dasgupta T; Castrucci WA; Weidhaas JB
    Cancer; 2008 Jul; 113(1):38-47. PubMed ID: 18442108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
    Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
    J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
    Ohri N; Moshier E; Ho A; Green S; Rhome R; Mazumdar M; Powell S; Tsai CJ
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):549-559. PubMed ID: 29280449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.